The Andhra Pradesh government released the results of AP Teacher Eligibility Test (APTET)-2025 on Friday.

The Select Committee has also recommended further updates to the worker classification “gateway test” to provide more ...

A California appeals court just rewrote the rules on who counts as a volunteer, creating headaches for HR teams across the ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 3.7% in the afternoon session after the ...

Zydus Lifesciences has signed an agreement with Myriad Genetics, a leader in molecular diagnostic testing and precision medicine company. Pursuant to the Agreement, Zydus will be introducing MyRisk ...

In order to launch cancer-risk assessment diagnostic tests in India, Ahmedabad-based Zydus Lifesciences Ltd has signed an exclusive agreement with US-based Myriad Genetics. As part of this agreement, ...

Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has signed an agreement with Myriad Genetics, a leader in molecular diagnostic testing and precision ...

Germline and somatic testing can inform treatment and family risk up front, but NGS is often held for recurrence, explained Courtney R. Arn, APRN-CNP. Biomarker testing for patients with ovarian ...

More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University of Sydney ...

Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying the women more likely to respond to an ovarian cancer treatment known as PARP inhibitor ...

A new clinical study has discovered a blood test that may help doctors predict which women with ovarian cancer are more likely to respond to a common treatment called PARP inhibitor therapy. This ...